Cookie Policy         The Babraham Research Campus is also home to The Babraham Institute


  Babraham Bioscience Technologies
        Babraham Research Campus - Cambridge - UK
 

News
  2014
  2013
  2012
  2011
  2010
  2009
  2008
  2007

Video Library

Events

Company Websites

Press Releases and Media Reports 2011

 

 

7th November 2011
Antitope, Ltd., Announces Antibody Research Agreement with Therapure Biopharma, Inc.

 

18th October 2011
Population Genetics raises $5.7M in a Series B financing and announces research agreement with Syngenta Biotechnology

 

20th September 2011
Spotlight on area's science potential
Cambridge News (Business)

 

6th September 2011
Growth Factor Technology to Accelerate the Dawn of Stem Cell Therapies

 

25th August 2011
MISSION Therapeutics, a new Cambridge-based spin-out company, secures £6M in Series-A funding led by Sofinnova Partners

 

9th August 2011
Cell Guidance Systems awarded £100k for the development of next generation growth factors

 

1st August 2011
Babraham Bioscience Technologies (BBT) becomes a One Nucleus Partner

 

27th July 2011
Antitope Ltd. Announces Research Cooperation with the University of North Carolina at Chapel Hill

 

20th July 2011 Business Weekly
Babraham hosts inaugural BioAcademic Showcase

 

22nd June 2011
Crescendo Biologics Appoints Matthew Roe as Chief Business Officer

 

16nd June 2011
Cell Guidance Systems Ltd today announces the launch of Pluripro® p300 media and Pluripro® MATRIX - a new way of maintaining and expanding culture of human pluripotent cells

 

14th June 2011
Antitope Ltd. Announces Humanization Research Agreement with IMMIH, University of Cologne

 

9th June 2011
Life at the core of the Cambridge cluster

 

7th June 2011
Antitope Ltd. Announces Humanization Research Agreement with NasVax Ltd.

 

6th June 2011
Babraham's Biotechnology Investment Forum 2011 fosters finance opportunities for 16 companies

 

27th May 2011
New addition to Babraham campus

 

May 2011
One Nucleus Newsletter

 

24th March 2011
Babraham Research Campus receives £44M boost for bioscience innovation

 

8th March 2011
Dennis Camilleri, Rapid Biosensor and Johnson & Johnson sign deal for TB Diagnostics

 

23rd February 2011
StemCells, Inc. to Present at New York Stem Cell Summit

 

22nd February 2011
Alpha Biologics and Viropro

 

17th February 2011
StemCells, Inc. Completes Dosing in Second Trial of HuCNS-SC(R) Neural Stem Cells

 

11th February 2011
Senexis featured in Business Weekly article

 

8th February 2011
StemCells, Inc. to Present at BIO CEO & Investor Conference

 

3rd February 2011
Eagle and Manchester sign KTA for Taverna

 

February 2011
Rapid Biosensor Systems announces a strategic agreement and collaboration on TB Diagnostics

 

24th January 2011
Eagle Genomics at Bench-to-Boardroom – March 8th2011

 

19th January 2011
StemCells, Inc. Broadens Its SC Proven(R) Product Portfolio With Launch of Two Additional Human Cell Detection Antibodies

 

17th January 2011
Eagle Genomics Symposium – April 5th 2011

 

14th January 2011
Building on a legacy in antibody research - report on BBSRC website

 

6th January 2011
Bicycle Therapeutics appoints Andy Sandham as non-executive Chairman

 

5th January 2011
Mike Romanos Appointed as CEO of Crescendo Biologics

 

4th January 2011
Eagle becomes an Amazon Solution Provider

 

 

 

Babraham Bioscience Technologies Ltd - Cambridge - United Kingdom